Budapest, Hungary

Zoltán Rátkai

This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Rt.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zoltán Rátkai. Retrieved from https://idiyas.com/inventor/zoltán-rátkai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zoltán Rátkai: Innovator in Pharmaceutical Chemistry

Introduction

Zoltán Rátkai is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzodiazepine derivatives. His research focuses on developing compounds with therapeutic potential.

Latest Patents

Zoltán Rátkai holds a patent for "2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient." This invention refers to novel 2,3-benzodiazepine derivatives that exhibit antispasmodic, muscle relaxant, and neuroprotective activities. The compounds are characterized by a specific formula where various groups and atoms are represented, showcasing the complexity and potential of his work.

Career Highlights

Throughout his career, Zoltán has been associated with Egis Gyogyszergyar Rt., a prominent pharmaceutical company. His role in the company has allowed him to explore and develop innovative solutions in drug formulation and therapeutic applications.

Collaborations

Zoltán has collaborated with esteemed colleagues such as István Ling and József Barkóczy. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Zoltán Rátkai's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the field. His work continues to impact the development of effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…